about
Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.Thymoma-associated graft-versus-host-like disease treated with high-dose i.v. immunoglobulin
P50
description
researcher
@en
name
Nodoka Sekiguchi
@en
type
label
Nodoka Sekiguchi
@en
prefLabel
Nodoka Sekiguchi
@en
P31
P496
0000-0002-0384-9611